Professional Documents
Culture Documents
PARENTERALS para: outside enteron: intestine (i.e. beside the intestine) These are the preparations which are given other than oral routes. Injections: These are Sterile, Pyrogen free preparations intended to be administered parenterally (outside alimentary tract).
Why Parenteral? Parenteral Route Is Used bcoz 1) Rapid action 2) Oral route can not be used 3) Not effective except as injection 4) Many new drugs particularly those derived from new development in biotechnologically can only be given by parenteral coz they are inactivated in GIT if given orally. 5) New drugs require to maintain potency & specificity so that they are given by parenteral.
Advantages:
Quick onset of action Suitable for the drugs which are not administered by oral route Useful for unconscious or vomiting patients. Duration of action can be prolonged by modifying formulation. Suitable for nutritive like glucose & electrolyte. Suitable for the drugs which are inactivated in GIT or HCl (GI fluid)
Disadvantages:
Once injected cannot be controlled (retreat) Injections may cause pain at the site of injection Only trained person is required If given by wrong route, difficult to control adverse effect Difficult to save patient if overdose Sensitivity or allergic reaction at the site of injection Requires strict control of sterility & non pyrogenicity than other formulation.
Routes of Parenteral Administration Subcutaneous (21) Intramuscular (20) Intra arterial (20-22) Intravenous (21)
Intradermal (23)
Epidermis
Dermis
Artery
Muscle
Parental Routes of Administration: Most Common: 1. Subcutaneous (SC; SQ ;Sub Q) 2. Intramuscular (IM) 3. Intravenous (IV) Others: 4. Intra-arterial (IA) 5. Intrathecal 6. Intraarticular 7. Intrapleural 8. Intracardial 9. Intradermal (Diagnostic)
The injection is given under the skin Need to be isotonic Upto 2 ml is given Using to 1 inch 23 gauge needle or smaller needle Vaccines Insulin Scopolamine Epinephrine
Given:
Intramuscular (IM):
Striated muscle fibre 0.5 to 2 ml sometimes upto 4 ml 1 to 1.5 inch & 19 to 22 gauge needle is used Preferably isotonic Principle sites: Gluteal (buttocks) Deltoid (upper arms) Vastus lateralis (lateral thigh) Given: Solutions Emulsions Oils Suspension
Intravenous (IV):
Into the vein 1 to 1000 ml 1 inch ,19 to 20 gauge needle with injection rate 1ml/ 10 sec. for volume upto 5 ml & 1 ml/ 20 sec. for volume more than 5 ml.
Given:
Aqueous solutions Hydro alcoholic solutions Emulsions Liposome
IV infusion of large volume fluids (100- 1000 ml) has become increasingly popular. This technique is called as Venoclysis. This is used to supply electrolytes & nutrients to restore blood volume & to prevent tissue dehydration. Combination of parenteral dosage forms for administration as a unit product is known as an IV admixture.
Lactated Ringer Injection USP NaCl Injection USP (0.9 %) (replenish fluid & electrolyte) Dextrose Injection USP (fluid & electrolyte)
Intra-arterial (IA):
Direct into the artery 2 to 20 ml 20 to 22 gauge Solutions & emulsions can be administered
Given:
Radio opaque media Antineoplastic Antibiotics
Intrathecal:
Also called intra-spinal Directly given into the spinal cord 1 to 4 ml 24 to 28 gauge Must be isotonic
Given:
LA Analgesics Neuroleptics
Intraarticular:
Given directly into the joints 2 to 20 ml 5 inch 22 gauge Must be isotonic
Given:
Morphine LA Steroids NSAIDs Antibiotics
Intrapleural:
Given directly into the pleural cavity or lung Used for fluid withdrawal 2 to 30 ml 2 to 5 inch, 16 to 22 gauge needle
Given:
LA Narcotics Chemotherapeutic agents
Intracardial:
Directly given into the heart 0.2 to 1 ml 5 inch , 22 gauge needle
Given:
Cadiotonics Calcium salts as a calcium channel blockers
Intradermal:
Also called as diagnostic testing 0.05 ml inch, 25 to 26 gauge needle Should be isotonic
Given:
Diagnostic agents
Official Types of Injections: 1. Solutions of Medicinal Example: Codeine Phosphate Injection Insulin Injection 2. Dry solids or liquid concentrate does not contain diluents etc. Example: Sterile Ampicillin Sodium 3. If diluents present, referred to as.....for injection Example: Methicillin Sodium for injection
4. Suspensions "Sterile....Suspension" Example: Sterile Dexamethasone Acetate Suspension 5.Dry solids, which upon the addition of suitable vehicles yield preparations containing in all respects to the requirements for sterile suspensions. Title: Sterile....for Suspension Example: Sterile Ampicillin for Suspension 6. Injectable Emulsions: Example: Propofol injection
Formulation of Parenteral:
1. Therapeutic agents 2. Vehicles i. Water ii. Water miscible vehicles iii. Non- aqueous vehicles 3. Added substances (Additives) i. Antimicrobials ii. Antioxidants iii. Buffers iv. Bulking agents v. Chelating agents vi. Protectants vii. Solubilizing agents viii. Surfactants ix. Tonicity- adjusting agents
6. Sterilization
7. Tests for Quality control
Formulation of Parenteral
1.Therapeutic ingredients:
Insulin Antibiotics Anticancer Steroids Vaccines Antipyretic Analgesics Anti- inflammatory LVPs like Dextrose, NaCl or combination etc.
Formulation of Parenteral
2.Solvents:
o Water
o
Ethyl alcohol
PEG PG
Fixed oils
Formulation of Parenteral
Solvents
Solvents used must be: Non-irritating Non-toxic Non-sensitizing No pharmacological activity of its own Not affect activity of medicinal
Formulation of Parenteral
3. Added substances (Additives) Antimicrobials:
Added for fungistatic or bacteriostat action or concentration Used to prevent the multiplication of microorganisms Ex..
Benzyl alcohol -----0.5 10 % Benzethonium chloride -- 0.01 % Methyl paraben ---0.01 0.18 % Propyl paraben --0.005 0.035 % Phenol --0.065 0.5 %
Preservatives: Multidose containers must have preservatives unless prohibited by monograph. Large volume parenteral must not contain preservative becoz it may be dangerous to human body if it contain in high doses.
Antioxidants:
Used to protect product from oxidation Acts as reducing agent or prevents oxidation Ex:
A) Reducing agent: Ascorbic acid -- 0.02 0.1 % Sodium bisulphite-0.1 0.15 % Sodium metabisulphite-- 0.1 0.15 % Thiourea 0.005 % B) Blocking agents: Ascorbic acid esters0.01 0.015% BHT0.005 0.02 % C) Synergistic: Ascorbic acid , Citric acid , Tartaric acid D) Chelating agent: EDTA0.01- 0.075 %
Buffers:
Added to maintain pH, Change in pH may causes degradation of the products Acetates, citrates, phosphates are generally used.
EXAMPLES:
Acetic acid ,adipic acid, benzoic acid, citric acid, lactic acid Used in the conc. of 0.1 to 5.0 %
Chelating agents: Used to form the complex with the metallic ions present in the formulation so that the ions will not interfere during mfg. of formulation. They form a complex which gets dissolved in the solvents.
Examples:
Disodium edetate 0.00368 - .05 % Disodium calcium edetate - 0.04 % Tetrasodium edetate 0.01 %
Stabilizers:
As parenterals are available in solution form they are most prone to unstabilize Used to stabilize the formulation Maintain stable
Examples:
Creatinine 0.5- 0.8 % Glycerin 1.5 2.25 % Niacinamide 1.25 -2.5 % Sodium saccharin 0.03 % Sodium caprylate 0.4 %
Solubilizing agents:
Used to increase solubility of slightly soluble drugs they acts by any one of the following: solubilizers, emulsifiers or wetting agents.
Examples:
Dimethylacetamide, Ethyl alcohol Glycerin Lecithin PEG 40 castor oil PEG 300 Polysorbate 20, 40, 80
Example:
Glycerin Lactose Mannitol Dextrose Sodium chloride Sorbitol
LABELING:
Name of product Quantity of the product % of drug or amount of drug in specified volume of amount of drug and volume of liquid to be added Name and quantity of all added substances Mfg. license no. Batch no. Manufacturer/Distributor Mfg. & Expiration date Retail price (incl. of all taxes) Mfger. address Veterinary product should be so labeled
Type of glass
Preparation of
IV fluids IV admixtures TPN Dialysis fluids
Sterile area
Production facilities:
Clean- up area Preparation area Aseptic area Quarantine area Finishing and packaging area
S T O C K
R O O M
COMPOUNDING AREA
ASEPTIC AREA
QUARANTINE AREA
Clean- up area:
Non aseptic area Free from dust ,fibres & micro-organisms
Constructed in such a way that should withstand moisture, steam & detergent
Ceiling & walls are coated with material to prevent
Preparation area:
The ingredients are mixed & preparation is prepared for
filling
Not essential that the area is aseptic Strict precaution is taken to prevent contamination from
outside
Cabinets & counters: SS Ceiling & walls : sealed & painted
Aseptic area:
Filtration & filling into final containers & sealing is done The entry of outside person is strictly prohibited To maintain sterility, special trained persons are only allowed to enter & work Person who worked should wear sterile cloths Should be subjected for physical examination to ensure the fitness Minimum movement should be there in this area Ceiling & walls & floors : sealed & painted or treated with aseptic solution and there should not be any toxic effect of this treatment
Fitted in laminar air flow system, in which air is free from dust & micro organisms flows with uniform velocity
Air supplied is under positive pressure which prevents particulate contamination from sweeping UV lamps are fitted to maintain sterility
Quarantine area:
After filling, sealing & sterilization the products or batch is kept in this area The random samples are chosen and given for analysis to QC dept. The batch is send to packing after issuing satisfactory reports of analysis from QC If any problem is observed in above analysis the decision is to be taken for reprocessing or others..
Volume supplied:
100 to 1000 ml
Examples:
Dextrose injection IP : available in 2 , 5 , 10 , 25 & 50 % w/v solution. Used for
Used for
As a diuretic
Other solutions:
Ringer injection IP Ringer lactate solution for injection IP
Common uses :
Used in surgery patients In replacement therapy Providing basic nutrition For providing TPN As a vehicle for other drug subs.
IV ADMIXTURES
Definition:
When two or more sterile products are added to an IV fluid for their administration, the resulting combination is known as IV admixture. In hospitals, prepared by nurses by combining or mixing drugs to the transfusion fluids. The drugs are incorporated in to bottles of LV transfusion fluids.
Care :
Microbial contamination Incompatibility
Physical : change in color Chemical : hydrolysis, oxidation, reduction etc.. Therapeutic: undesirable antagonistic or synergistic effect
TPN stands for Total Parenteral Nutrition. This is a complete form of nutrition, containing protein, sugar, fat and added vitamins and minerals as needed for each individual. Total Parenteral Nutrition (TPN) may be defined as provision of nutrition for metabolic requirements and growth through the parenteral route.
Components
of TPN solutions:
(1) Protein as crystalline amino acids. (2) Fats as lipids. (3) Carbohydrate as glucose. (4) ElectrolytesSodium, potassium, chloride, calcium and magnesium. (5) Metals/Trace elementsZinc, copper, manganese, chromium, selenium. (6) Vitamins A, C, D, E, K, thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, biotin, choline and folic acid.
Why it is necessary?
Nutritional Requirements
Amino acids Glucose Lipid Minerals Vitamins Water and electrolytes Trace elements
Phos.
30-50 mM
12-15 mM/L
When is it necessary?
TPN is normally used following surgery, when feeding by mouth or using the gut is not possible, When a person's digestive system cannot absorb nutrients due to chronic disease, or, alternatively, if a person's nutrient requirement cannot be met by enteral feeding (tube feeding) and supplementation.
Short-term TPN may be used if a person's digestive system has shut down (for instance by Peritonitis), and they are at a low enough weight to cause concerns about nutrition during an extended hospital stay. Long-term TPN is occasionally used to treat people suffering the extended consequences of an accident or surgery. Most controversially, TPN has extended the life of a small number of children born with nonexistent or severely birth-deformed guts.
GENERAL INDICATIONS
Patient who cant eat Patient who wont eat Patient who shouldnt eat Patient who cant eat enough If the gut works, use it.
NOMENCLATURE
TPN: Total Parenteral Nutrition IVH: Intravenous Hyperalimentation TNA: Total Nutrient Admixture TPN: Total Parenteral Nutrition 3-In-1 Admixture All-In-One Admixture PPN: Peripheral Parenteral Admixture
Bowel injury /surgery Bowel disease Severe malnutrition Nutritional preparation prior to surgery. Malabsorption - bowel cancer
Long-term use
The preferred method of delivering TPN is with a medical infusion pump. A sterile bag of nutrient solution, between 500 mL and 4 L is provided. The pump infuses a small amount (0.1 to 10 mL/hr) continuously in order to keep the vein open. Feeding schedules vary, but one common regimen ramps up the nutrition over a few hours, levels off the rate for a few hours, and then ramps it down over a few more hours, in order to simulate a normal set of meal times.
The nutrient solution consists of water, glucose, salts, amino acids, vitamins and (more controversially) sometimes emulsified fats. Long term TPN patients sometimes suffer from lack of trace nutrients or electrolyte imbalances. Because increased blood sugar commonly occurs with TPN, insulin may also be added to the infusion. Often though, an insignificant amount of insulin is added, sometimes 10 units or less in 2 liters of TPN. In actuality, the patient will probably get less than that. Occasionally, other drugs are added as well, sometimes unnecessarily.
Complications of TPN
Sepsis Air embolism Clotted catheter line Catheter displacement Fluid overload Hyperglycaemia Rebound Hypoglycaemia
DIALYSIS FLUIDS
Dialysis is the process in which substances are separated from one another due to their difference in diffusibility (distribution) thr membrane. The fluids used in dialysis are known as dialysis fluids.
General uses :
Renal failure
waste product is removed Maintain electrolytes Also called as haemodialysis or intraperitoneal dialysis
Haemodialysis:
To remove toxins from blood In haemodialysis, the blood from artery is passed thr artificial dialysis membrane, bathed in dialysis fluid. The dialysis membrane is permeable to urea, electrolytes & dextrose but not to plasma proteins & lipids So excess of urea is passed out from blood thr dialysis fluid.
After dialysis blood is returned back to the body circulation thr vein. A kidney unit may require more than 1200 litres of solution / week. So haemodialysis fluid is prepared in conc. Form then it is diluted with deionised water or dist. water before use.
COMPOSITION
Composition of Concentrated Haemodialysis Fluid BPC
Dextrose monohydrate ----------Sodium acetate --------------------Lactic acid --------------------------Sodium chloride ------------------Potassium chloride --------------Freshly boiled & cooled water -q.s.
Dilute 1 liter of conc. solution with 39 liters of water to make 40 litres. Storage: store in warm place as it is liable to convert into crystals on storage.
Intraperitoneal Dialysis:
Peritoneal cavity is irrigated with dialysis fluid. Peritoneum acts as a semi permeable membrane Toxic subs. excreted by kidney are removed. Requirements:
Sterile Pyrogen free
COMPOSITION
Sterility testing attempts to reveal the presence or absence of viable microorganisms in a sample number of containers taken from batch of product. Based on results obtained from testing the sample a decision is made as to the sterility of the batch.
Sterility testing is made after the product exposition to the one of the possible sterilization procedures can only provide partial answers to the state of sterility of the product batch under test is inadequate as an assurance of sterility for a terminally sterilized product
The environment in which the test is conducted The quality of the culture conditions provided The test method The sample size
The sampling procedure
1.1.Environmental conditions
avoid accidental contamination of the product during the test the test is carried out under aseptic conditions regular microbiological monitoring should be carried out
1.2.Culture conditions
Appropriate conditions for the growth of any surviving organism should be provided by the culture media selection.
Lag phase (A) Log (logarithmic or exponential) phase (B) Stationary phase (C) Decline (death) phase (D)
14 days at 30 -35C
14 days at 20 -25C
Appropriate for : (advantage) filterable aqueous preparations alcoholic preparations oily preparations preparations miscible with or soluble in aqueous or oily (solvents with no antimicrobial effect) solutions to be examined must be introduced and filtered under aseptic conditions All steps of this procedure are performed aseptically in a Class 100 Laminar Flow Hood
sterilization of filtration system and membrane filtration of examined solution under aseptic conditions (suitable volume, dissolution of solid particles
with suitable solvents, dilution if necessary)
one of two possible following procedures: the membrane is removed, aseptically transferred to container of appropriate culture medium passing the culture media through closed system to the membrane, incubation in situ in the filtration apparatus (sartorius, millipore).
1.5. Sampling
Instead of the conclusion - Guidelines for using the test for sterility
Precautions against microbial contamination The level of assurance provided by a satisfactory result of a test for sterility as applied to the quality of the batch is a function of:
The homogeneity of the batch The conditions of manufacture Efficiency of the adopted sampling plan
Guidelines
only analytical method available to the authorities who have to examine a specimen of a product for sterility.
Pyrogens
Pyrogenic - means producing fever Pyrogens - fever inducing substances
Having nature
Endogenous (inside body) Exogenous (outside body) mainly lipopolysaccharides bacterial origin, but not necessary
Exogenous pyrogens
Structure of endotoxins
Produced mostly by gram-negative bacteria Endotoxin - complex of pyrogenic lipopolysaccharide, a protein and inert lipid; lipid part of the lipopolysaccharide is the main pyrogenic agent; polysaccharide part increases solubility
>48 hours within negative result >2 weeks within a positive result
Rabbit test
selection of animals (healthy, adult, not less than 1.5 kg,) housing of animals (environmental problems: presence of strangers (unknown place), noise, T, ) equipment and material used in test (glassware, syringes, needles) retaining boxes (comfortable for rabbits as possible) thermometers (standardized position in rectum, precision of 0.1C)
Rabbit test
Rabbit test
main test: group of 3 rabbits preparation and injection of the product: warming the product dissolving or dilution duration of injection: not more than 4 min the injected volume: not less than 0.5 ml per 1 kg and not more than 10 ml per kg of body mass determination of the initial and maximum temperature all rabbits should have initial T: from 38.0 to 39.8C the differences in initial T should not differ from one another by more than 1C
Rabbit test
0.6 0.6
1.4 3.7
Passes Passes
If above test not passes, the sample is said to be pyrogenic or go thr the sources of contamination of pyrogen.
Bacterial endotoxins
to detect or quantify endotoxins of gramnegative bacterial origin reagent: amoebocyte lysate from horseshoe crab (Limulus polyphemus or Tachypleus tridentatus). The name of the test is also Limulus amebocyte lysate (LAL) test
Mechanism of LAL
the test is based on the primitive bloodclotting mechanism of the horseshoe crab
enzymes located with the crab's amebocyte
blood cells endotoxins initiation of an enzymatic coagulation cascade proteinaceous gel
Commercially derived LAL bleeding adult crabs reagents into an anticlotting solution
washing and centrifuging to collect the amebocyte lysing in 3% NaCl lysate is washed and lyophilized for storage activity varies on a seasonal basis and standardization is necessary.
Test:
equal V of LAL reagent and test solution (usually 0.1 ml of each) are mixed in a depyrogenated test-tube incubation at 37C, 1 hour remove the tube - invert in one smooth motion (180) - read (observe) the result pass-fail test
LAL test
LAL test
In the event of doubt or dispute, the final decision is made upon Method A unless otherwise indicated in the monograph.
allows detection or quantification of endotoxins clotting of the lysate in the presence of endotoxins. 1.Preparatory testing Confirmation of the labeled lysate sensitivity Tests for interfering factors
Invert Tube in Smooth Motion
Gel Clot
2. Limit test (method A) procedure described on page. 24 a firm gel - positive result. an intact gel is not formed - negative result. the interpretation of the results
3. Semi-quantitative test (method B) quantification of bacterial endotoxins in the test solution by titration to an end-point. procedure is similar as in the limit test The results are expressed as concentration of endotoxin as less, equal or greater than (labeled lysate sensitivity).
photometric test to measure the increase in turbidity end-point test (Method F): quantitative relationship
between the endotoxin concentration and the turbidity (absorbance or transmission) of the reaction mixture at the end of an incubation period.
measuring the chromophore released from a suitable chromogenic peptide by the reaction of endotoxins with the lysate end-point test (Method E): is based on the quantitative
relationship between the endotoxin concentration and the quantity of chromophore released at the end of an incubation period
the absence of bacterial endotoxins in a product implies the absence of pyrogenic component if you wish to replace rabbit test you should prove that you dont have interfering factors if rabbit pyrogen test is replaced by endotoxin test, the last one should be validated methods from C to F require more instrumentation, but they are easier to automate test for bacterial endotoxins is preferred over the test for pyrogens
Definition:
Unwanted mobile insoluble matter other than gas bubbles present in the given product. It may be dangerous when the particle size is larger than R.B.C. & may block the blood vessel. This type of products are immediately rejected from the batch.
The limit test for particulate matter is prescribed in I.P. 1996 (A- 125) Applicable for:
100 ml or more volume containers of single dose LV given by IV infusion
Intrinsic contamination:
Originally present in products
e.g. Barium ions may react or leach with Sulphur ion which are already present in formulation may produce barium sulphate crystals.
Extrinsic contamination:
Material comes from outside or environment
e.g. coming off the material from body & cloths of person Entry of particle from ceiling , walls & furniture May be in the form of cotton, glass rubber, plastics, tissues, insect fragments, bacterial contamination, dust, papers etc
Visual method Coulter counter method Filtration method Light blockage method
Visual method:
Simple method Filled container are examined against strong illuminated screen by holding neck & rotating it slowly or inverted it to keep out the foreign matter.
Filtration method:
It is used for counting the particles in hydraulic fluids. Sample passed thr filter Material is collected on filter Evaluated under microscope. Disadvantage:
As per USP
LVP : NMT 50 particles/ ml (size 10 or more than 10 micrometer) & 5 particles/ ml (size more than 25 micrometer) SVP: 10,000 particles/ container of size 10 micrometer or greater & NMT 1000 particles/ container greater than 25 micrometer.